Today's signals · No active technical signal.
Signal details →Kymera Therapeutics last closed at $109.85 (+2.29%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -36.0×. Its overall grade ranks 22 of 741 stocks in Healthcare.
About this company
Kymera Therapeutics last closed at $109.85 (+2.29%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 22/741
Valuation grade A-
Related stocks
- SanofiCustomer
Kymera의 면역질환 후보물질 공동개발 파트너로 주요 기술이전·협력사
- Bristol Myers SquibbCustomer
Kymera의 분자접착 분해제 플랫폼 관련 초기 협력 파트너로 기술가치에 중요한 고객
- MerckCompetitor
표적단백질 분해제·면역/종양 신약 개발에서 경쟁하는 대형 제약사
ETFs holding this stock
SPDR S&P Biotech ETF
Details →About Kymera Therapeutics
- What technical signals does Kymera Therapeutics (KYMR) have?
- Kymera Therapeutics current technical signals: no active technical signal.
- Is Kymera Therapeutics a cup-and-handle pattern?
- No. Kymera Therapeutics has no valid Cup signal right now.
- What published figures are available for Kymera Therapeutics?
- Market cap: $8.77B. Trailing 12 months PER: -36.0×. Latest quarter PBR: 7.15×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Kymera Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.